JOURNAL OF CHEMICAL RESEARCH 2009 703
Br
Br
CO2Bu
CO2Bu
Br
Br
CO2Bu
CHCl3
+
SO
S
O
D
CO2Bu
4a
5
6
(89%)
O
O
Br
Br
Br
Br
Ph
Ph
Ph
CHCl3
+
SO
S
O
D
Ph
O
O
3
7
(82%)
4a
O
O
R
R
R
R
CHCl3
SO
N-Ph-p-X
N-Ph-p-X
S
O
+
D
O
O
4b: R = CH3, 4c: R = CH2Ph
8a: X = Cl; 8b: X = H
9a: R = CH3, X = Cl (78%)
9b: R = CH2Ph, X = H (75%)
Scheme 2 Cycloaddition of thiophene S-oxides to alkenes.
326.1307). nmax (neat/cm-1) 2994, 2974, 2948, 1648, 1598, 1449,
1317, 1290, 1279, 947, 865, 703, 660; dH (270 MHz, CDCl3) 1.55
(1H, d, 2J = 9.6 Hz), 1.74 (1H, d, 2J = 9.6 Hz), 2.89 (2H, d, J = 1.7 Hz),
2.91 (2H, brs), 6.52 (2H, s), 7.22–7.72 (10H, m); dC (67.8 MHz,
CDCl3) 39.4, 40.1, 45.4, 128.5, 128.8, 133.2, 136.0, 136.7, 149.9,
190.8; MS (EI, 70 eV) m/z (%) = 326 (M+) (30).
Dibutyl 2,3-dibromo-1,4-dimethyl-7-thiabicyclo[2.2.1]hept-2-ene-5,
6-dicarboxylate 7-oxide (6): A mixture of 3,4-dibromo-2,5-dimethyl-
thiophene S-oxide (4a) (150 mg, 0.52 mmol) and dibutyl maleate (5)
237 mg, 1.04 mmol) in chloroform (2 mL) was heated under reflux
for 24 h. Thereafter, the solution was cooled and concentrated in
vacuo. The residue was subjected to column chromatography on silca
gel (hexane/ether 2:1) to give 6 (240 mg, 89%) as a colourless solid;
m.p. 69–70°C. (Found: M+, 513.9848. C18H26O579Br81BrS requires
M+, 513.9847). nmax (neat/cm-1) 2960, 2870, 1737, 1566, 1450, 1383,
1328, 1282, 1246, 1171, 1146, 1110, 1084, 1063, 1025, 950. dH (270
MHz, CDCl3) 0.93 (6H, t, 3J = 7.2 Hz, 2 CH3), 1.36 (4H, m), 1.59 (4H,
m), 1.68 (6H, s, 2 CH3), 3.89 (2H, s), 4.04 (4H, m); dC (67.8 MHz,
CDCl3, DEPT 90, DEPT 135) 13.7 (+, 2C, CH3), 15.5 (+, 2C, CH3),
N-Phenyl-5,6-benzyl-1,4-dimethyl-7-thiabicyclo[2.2.1]hept-5-
ene-2,3-carboxamide 7-oxide (9b): A solution of 3,4-dibenzyl-
2,5-dimethylthiophene S-oxide (4c, 406 mg, 1.32 mmol) and
N-phenylmaleimide (8b, 250 mg, 1.45 mmol) in CHCl3 (4 mL) was
stirred at 60°C for 18 h under an inert atmosphere. Thereafter, the
solvent was evaporated in vacuo and the residue was subjected to
a short column chromatography on silica gel (ether/CHCl3/hexane
2:1:1) to give 9b (475 mg, 75%) as a colourless solid, m.p. 73°C.
(Found: M+, 481.1718. C30H27NO3S requires M+, 481.1712). nmax
(KBr/cm-1) 1700, 1060; dH (270 MHz, CDCl3) 1.67 (6H, s, 2 CH3),
2
3.56 (2H, d, J = 16.0 Hz), 3.76 (2H, s), 3.82 (2H, d, 2J = 16.0 Hz),
7.04–7.52 (15H, m); dC (67.8 MHz, CDCl3) 13.5, 32.7, 51.2, 73.9,
126.1, 126.8, 128.4, 128.7, 128.8, 129.0, 129.1, 131.6, 137.0, 137.1,
174.1; MS (EI, 70 eV) m/z (%) = 433 (M+-SO, 47), 342 (6.9), 193
(100). Anal Calcd for C30H27NO3S (481.60): C, 74.82; H, 5.65; N,
2.91. Found: C, 74.82; H, 5.84; N, 2.83%.
Dibutyl 2,3-dibromo-1,4-dimethyl-7-thiabicyclo[2.2.1]hept-2-ene-
5,6-dicarboxylate (10): A solution of 7 (114 mg, 0.22 mmol) and PBr3
(110 µL, 313 mg, 1.16 mmol) in dry DMF (2.0 mL) was set at 0°C
and stirred at r.t. for 25 min. Thereafter, the mixture was cooled again
to 0°C and ether (10 mL) was added. Then, water (300 µL) was added
dropwise. The mixture was extracted with water (15 mL) and ether
(2 × 15 mL). The combined organic phase was dried over anhydrous
MgSO4 and concentrated in vacuo. Column chromatography on silica
gel (hexane/ether 2.5:1) gave 10 (71 mg, 65%) as a colourless oil.
(Found: M+, 497.9896. C18H26O479Br81BrS requires M+, 497.9899).
nmax (neat/cm-1) 2956, 2854, 1748, 1587, 1459, 1382, 1195; dH
19.1 (–, 2C), 30.4 (–, 2C), 52.7 (+, 2C, CH), 65.6 (–, 2C), 75.2 (Cquat
,
2C), 125.4 (Cquat, 2C), 169.1 (Cquat, 2C). MS (70 eV) m/z (%) = 516
([81Br2]M+, 4), 514 ([81Br79Br]M+, 8), 512 ([79Br2]M+, 4), 468 ([81Br2]
M+-SO, 38), 264 (100).
5,6-Dibenzoyl-11,12-dibromo-1,10-dimethyl-14-thiapentacyclo-
[8.2.1.1.3,80.2,90.4,7]penta-deca-5,11-diene 14-oxide (7): A solution of
3 (100 mg, 0.31 mmol) and 4a (44 mg, 0.15 mmol) in chloroform
(1.5 mL) was held at reflux for 21 h. Then, the cooled solution was
concentrated in vacuo and subjected to column chromatography on
silica gel (ether/hexane 1:1) to give 7 (75 mg, 82%) as a colourless
solid; m.p. 184°C. (Found: MH+, 612.9870. C29H25O379Br81BrS
requires MH+, 612.9873 [FAB]). nmax (KBr/cm-1) 3054, 3026, 2960,
2920, 1653, 1597, 1444, 1315, 1286, 1110, 712, 687, 656; dH (270
MHz, CDCl3) 1.48 (2H, m), 1.65 (6H, s, 2 CH3), 2.51 (2H, bs), 2.52
(2H, bs), 3.07 (2H, bs), 7.18–7.24 (4H, m), 7.33–7.39 (2H, m), 7.60–
7.63 (4H, m); 13dC (67.8 MHz, CDCl3, DEPT, DEPT 135) 16.2 (+,
2C, CH3), 27.8 (–, 2C), 35.0 (+, 2C, CH), 42.3 (+, 2C, CH), 53.3 (+,
2C, CH), 77.2 (Cquat, 2C), 125.8 (Cquat, 2C), 128.5 (+, 4C, CH), 128.8
(+, 4C, CH), 133.4 (+, 2C, CH), 136.4 (Cquat, 2C), 145.9 (Cquat, 2C),
190.5 (Cquat, 2C, C=O); MS (FAB, 3-nitrobenzyl alcohol) m/z (%) =
613 (MH+, 35), 564 (15).
3
(270 MHz, CDCl3) 0.92 (6H, t, J = 7.5 Hz, 2 CH3), 1.20–1.34 (4H,
m), 1.56 (4H, m), 1.78 (6H, s, 2 CH3), 3.94 (2H, s), 3.92–4.10 (4H,
m); dC (67.8 MHz, CDCl3) 13.7 (+, 2C, CH3), 19.2 (+, 2C, CH3 and
2C, CH2), 30.5 (–, 2C), 60.7 (+, 2C, CH), 65.1 (–, 2C), 65.9 (Cquat
,
2C), 132.3 (Cquat, 2C), 169.3 (Cquat, 2C, C=O); MS (70 eV) m/z (%) =
500 ([81Br2]M+, 10), 498 ([79Br81Br]M+, 19), 496 ([79Br2]M+, 10), 419
(M+-Br, 31), 417 (M+-Br, 30), 308 (94), 271 (52), 269 (100), 267 (50).
5,6-Dibenzoyl-11,12-dibromo-1,10-dimethyl-14-thiapentacyclo-
[8.2.1.1.3,80.2,90.4,7]penta-deca-5,11-diene (11): A solution of
7
(67 mg, 0.11 mmol) and PBr3 (110 µL, 313 mg, 1.16 mmol) in dry
DMF (1.5 mL) was set at 0°C and stirred at r.t. for 25 min. Thereafter,
the mixture was cooled again to 0°C and ether (10 mL) was added.
Then, water (300 µL) was added dropwise. The mixture was
extracted with water (15 mL) and ether (2 × 15 mL). The combined